key: cord-0813908-a1yqtbsj
authors: Adegboyega, Abayomi Emmanuel; Johnson, Titilayo Omolara; Omale, Simeon
title: Computational modeling of the pharmacological actions of some antiviral agents against SARS-CoV-2
date: 2021-05-21
journal: Data Science for COVID-19
DOI: 10.1016/b978-0-12-824536-1.00018-6
sha: 5a77cf23c01067707025ed5cac8a5cfd16b6e71f
doc_id: 813908
cord_uid: a1yqtbsj

This study aimed to evaluate the pharmacological and toxicological potential of five known antiviral agents and their derivatives through computational modeling. Ritonavir, remdesivir, chloroquine, lopinavir, lieckol, and their derivatives were subjected to molecular docking analysis against five SARS-CoV-2 target proteins. The absorption, distribution, metabolism, excretion, and toxicity properties of the compounds with high affinity for the SARS-CoV-2 target proteins were predicted. Dieckol demonstrated the highest binding affinity for all the SARS-CoV-2 target proteins, while lopinavir and ritonavir showed a relatively high-binding affinity for 3-chymotrypsin-like protease, main protease, and RNA-dependent RNA polymerase. The compounds fulfilled the Lipinski rule, possess moderate water solubility, gastrointestinal absorption absorption, bioavailability, synthetic accessibility, and optimum lipophilicity. Hence, this study proves the therapeutic potential of dieckol, lopinavir, and ritonavir.

SARS-CoV-2 target proteins were gotten from the protein data bank (PDB) and the structure data file format or canonical smiles of the test compounds were obtained from the PubChem database and then converted to PDB format using UCSF Chimera 1.14. AutoDock 4.2 was used to prepare PDBQT format files for target and ligand docking. Molecular docking was performed using AutoDock vina in PyRx and finally, the results were analyzed using UCSF Chimera 1.14 and Discovery Studio 2020 [3, 17, 18 ].

Absorption, distribution, metabolism, excretion, and toxicity (ADMET) of the antiviral drugs and their structurally related lead compounds were determined using an in silico integrative model predicted at the SwissADME and PROTOX-II web servers, respectively. Using a huge database, the servers speculate physicochemical properties, lipophilicity, water solubility, pharmacokinetics, drug-likeness, medicinal properties, and toxicity of compounds with high precision [19] .

A library of ligands (the five antiviral drugs and their structurally similar lead compounds) was created from PubChem and SwissSimilarity database, respectively. The candidates in the obtained library were subjected to molecular docking using AutoDock Vina program in PyRX software. The ligands with high-docking score were filtered by Lipinski's rule and by their SwissADME physicochemical properties. Only the molecules which following Lipinski's rule and SwissADME predictions can be considered as hits were subjected to post-docking analysis using Discovery Studio 2020 and UCSF Chimera 1.14, and toxicity screening using PROTOX-II web server. Top-ranked candidates were suggested for experimental screening as potential therapeutic agents for the treatment of SARS-CoV-2 [18] .

Statistical analysis was performed by one-way ANOVA using GraphPad Prism 8.02, and the results were expressed as mean AE SEM. Group differences were determined by Tukey's multiple comparison test (P < .05). The statistical comparison and ranking of the first 14 compound with highest binding energy with all target SARS-CoV-2 proteins showed that dieckol, CHEMBL3120784, Lopinavir, WD5DUG7X38, and ZINC82312352 were ranked the first five compounds with highest binding affinity. The average binding affinity of dieckol with all target proteins was significantly higher (P < .05) when compared with other ligands (Fig. 25.2 ).

SwissADME predicted values of pharmacokinetics, pharmacodynamics, and druglikeness of the 14 selected compounds showed that most of the compounds fulfilled the important criteria for drug-likeness and optimal toxicity as obtained from SwissADME screening. The result showed that the compounds relatively fulfilled the Lipinski rule of 5, have moderate water solubility, gastrointestinal absorption (GI) absorption, bioavailability, synthetic accessibility, and optimum lipophilicity as expressed in Tables 25.3 and 25 .4, respectively. Considering all the models for water solubility: ESOL Log S, Ali Log S, Silicos-IT LogSw, we can infer that most of the selected compounds are moderately water-soluble.

The PROTOX-II predicted toxicity profile of the selected compounds showed that the majority of the compounds demonstrated no toxic effects against drug toxicity targets and toxicological pathways. Although Lopinavir was predicted to have slight toxic effects against mitochondrial membrane potential, dieckol with aryl hydrocarbon receptor (AhR), while ZINC82312352 and ZINC82312351 may exhibit AhR, estrogen receptor alpha, estrogen receptor ligand binding domain, mitochondrial membrane potential, and phosphoprotein (tumor suppressor) p53 toxicity (Table 25 .5). Hepatotoxicity À À þ À À À À À À À À À À À Carcinogenicity À À À À À À À À À À À À À À Immunotoxicity À À À À À À À À À À À À À À Mutagenicity À À À À À À À À À À À À À À Cytotoxicity À À À À À À À À À À À À À À (AhR) þ À À À À þ þ À À À À À À À (AR) À À À À À À À À À À À À À À (AR-LBD) À À À À À À À À À À À À À À Aromatase À À À À À þ þ À À À À À À À (ER) À À À À À þ þ À À À À À À À (ER-LBD) À À À À À þ þ À À À À À À À (PPAR-Gamma) À À À À À À À À À À À À À À (nrf2/ARE) À À À À À À À À À À À À À À (HSE) À À À À À À À À À À À À À À (MMP) þ þ À À À þ þ À À À À À À À p53 À À À À À þ þ À À À À À À À (ATAD5) À À À À À À À À À À À À À À 

Figs. 25.3e25.9 shows the molecular docking interactions of some selected compounds with a high-binding affinity toward corresponding target proteins of SARS-CoV-2. The molecular mechanism calculations showed that dieckol binds to 3CLpro of SARS-CoV-2 with at least eight conventional hydrogen bonds among others, which may likely be the reason while it has the highest binding affinity with 3CLpro among all the compounds screened ( Fig. 25.3) . However, molecular complexation of lopinavir with the 3-CLpro involved the following bonds: van der Waals, Conventional Hydrogen Bond, Carbon Hydrogen Bond, Pi-Donor Hydrogen Bond, Pi-Pi Stacked, Pi-Pi T-Stacked, Amide-Pi Stacked, Alkyl and Pi-Alkyl Bond (Fig. 25.4) (Fig. 25.8) . Also, the molecular interactions of selected compounds with RdRp of SARS-CoV-2 showed that all the ligands bind fitly to the same binding site of the enzyme with dieckol having the strongest complexation bonds (Fig. 25.9 ). 

The molecular docking analysis of the five antiviral agents and their derivatives show that dieckol has the highest binding affinity with all the SARS-CoV-2 target proteinsd spike (S) protein, RdRp, 3CLpro, PLpro, and main protease (Table 25 .1). Dieckol is a phlorotannin made up of two monomeric structures of eckol, a polyphenolic compound. It has been reported that dieckol has antiviral, antitumor, antidiabetic, antioxidant, antiinflammatory, antiadipogenic, and radio-protective effects [9,20e23] . Dieckol has shown broad-spectrum antiviral activity against viruses such as porcine epidemic diarrhea virus, viral hemorrhagic septicemia virus, human papillomavirus, murine norovirus, human immunodeficiency virus, and coronavirus (SAR-CoV) [9, 23, 24] . Park et al. 2013 showed that dieckol isolated from the edible brown algae Ecklonia cava is a SARS-CoV 3CLpro inhibitor. In this study, we found that dieckol was able to dock in the binding site of SARS-CoV-2 target proteins with additional hydrogen among others. This may explain why dieckol had the highest binding affinity than the other chemical compounds that were screened. It is, therefore, possible that dieckol could inhibit SARS-CoV-2 activity by blocking the active site of its target proteins in the groove. Lipophilicity is a major factor that contributes to the ADMET characteristics of drugs and a limit of log P < 5 according to Lipinski is, therefore, an acceptable lipophilicity range for compounds reaching Phase II clinical trials [25, 26] . Dieckol, from the result obtained from five different lipophilicity model of SwissADME (Table 25 .4), showed positive. These positive values signify that the molecules have an optimal lipophilic property and fulfill the essential criteria for drug molecules, Log P < 5 [19] . Also, the water solubility predictions from SwissADME (Table 25. 3) showed dieckol to be moderately water-soluble. This suggests that the molecules may be administered in the body through an oral or parenteral route. Furthermore, the toxicity test from PROTOX-II showed that dieckol is relatively not toxic to the human host's toxicity targets and toxicological pathways (Table 25 .5).

Lopinavir in combination with Ritonavir is another therapy with good inhibitory activity against the 2019-nCoV. Ritonavir was reported to inhibit the metabolizing enzyme cytochrome P450 3A and therefore increases the half-life of Lopinavir [16,26e28] . In this study, Lopinavir showed relatively high-binding affinity and effectively docked with the binding site of 3CL-pro and RdRp target proteins of SARS-CoV-2. This may explain the potential inhibitory activity of lopinavir against SARS-CoV-2 (Table 25 .1 and Fig. 25 .5). The molecule relatively fulfills the Lipinski rule of 5, have moderate water solubility, GI absorption, bioavailability, synthetic accessibility, and optimal lipophilicity as expressed on Tables 25.3 and 25.4, respectively. PROTOX-II test showed that lopinavir is relatively not toxic to the host's toxicity targets and toxicological pathways (Table 25.5) .

Although Chloroquine has been reported to have inhibitory activity against 2019-nCoV, its binding affinity with all the target proteins in this study was relatively low (Table 25 .1 and Fig. 25.1 ). This observation suggests that its mechanism of action may not necessarily be through direct inhibition of the viral proteins. Smith et al., suggested that acidification of the cell membrane surface receptor and immunomodulation of cytokine release may be the mechanism used by chloroquine to inhibit fusion of the viral spike protein with ACE2 of the human host [28] .

The results obtained in this study suggest that dieckol, lopinavir, and ritonavir possessed inhibitory potential against SARS-CoV-2 targets spike (S) protein, 3CLpro, RdRp, and PLpro. They were also found to possess acceptable ADMET properties. These compounds could therefore be further explored in the establishment of therapeutic interventions against COVID-19.

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Structure, function, and antigenicity of the SARS-structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Lopinavir; a potent drug against coronavirus infection: insight from molecular docking study

Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava

SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules

ProTox-II: a webserver for the prediction of toxicity of chemicals

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID-19. The COVID-19 Resource Centre Is Hosted on

The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase

Crystal structure of SARS-CoV-2 main protease provides a basis for the design of improved a-ketoamide inhibitors

Why are lopinavir and ritonavir effective against the newly emerged Coronavirus 2019?: atomistic insights into the inhibitory mechanisms

In silico drug design and molecular docking studies of potent inhibitors against cathepsin-L (CTSL) for sars disease

In silico studies on novel inhibitors of MERS-CoV: structure-based pharmacophore modeling, database screening and molecular docking

In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme

Chapter 8 e Medicinal Effects of Phlorotannins from Marine Brown Algae

Phlorotannins and Fucoidans from Marine Macroalgae as Matrix Metalloproteinase Inhibitory Substances and Their possible Application as Medicinal Foods

In vitro antiviral activity of dieckol and phlorofucofuroeckol-A isolated from edible brown alga Eisenia bicyclis against murine norovirus

Dereplication by high-performance liquid chromatography (HPLC) with quadrupole-time-of-flight mass spectroscopy (qTOF-MS) and antiviral activities of phlorotannins from Ecklonia cava

The Influence of Lipophilicity in Drug Discovery and Design

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

A trial of lopinavireritonavir in adults hospitalized with severe Covid-19

COVID-19 Drug Therapy e Potential Options Highlights: Antimicrobials with Potential Activity against SARS-CoV

Dieckol, a component of Ecklonia cava, suppresses the production of MDC/CCL22 via down-regulating STAT1 pathway in interferon-g stimulated HaCaT human keratinocytes

Lopinavir/ritonavir: A